An internal NIH database was queried for endocrine surgery-related grants awarded to surgeons in 2010, 2015, and 2020. The grants were then compared based on cost, grant type, research type, and endocrine topic.
Eighteen grants ($6.4 M) focused on endocrine surgery-related research topics were identified in 2020, 17 ($7.3 M) in 2015, and 11 ($3.8 M) in 2010. In 2020, 14 grants were basic science and 4 were clinical outcomes, and pancreatic endocrine disease and thyroid disease each comprised 6 grants. R01 and R21 grants comprised 10 (55.6%) of the grants in 2020, compared to 10 (58.5%) in 2015 and 8 (72.7%) in 2010, while K08 and K23 grants increased to 4 (22.2%) in 2020 from 2 (11.8%) in 2015 and none in 2010.
There were more K-awards focused on endocrine surgery-related research in 2020 compared to 2015 and 2010, suggesting the pipeline is growing.
方法:在2010年、2015年和2020年向NIH内部数据库查询授予外科医生的内分泌手术相关资助。然后根据成本比较赠款,授予类型,研究类型,和内分泌话题。
结果:2020年确定了18笔赠款(6.4百万美元),重点是内分泌手术相关的研究课题,2015年确定了17笔赠款(7.3百万美元),2010年确定了11笔赠款(3.8百万美元)。2020年,14项资助是基础科学,4项是临床成果,胰腺内分泌疾病和甲状腺疾病各包含6项资助。R01和R21赠款占2020年的10笔(55.6%),而2015年为10笔(58.5%),2010年为8笔(72.7%),而K08和K23赠款从2015年的2笔(11.8%)增加到2020年的4笔(22.2%),2010年没有。
结论:与2015年和2010年相比,2020年有更多的K-奖项集中在内分泌手术相关研究上,这表明管道正在增长。